Abstract: A compression bandage in the form of a knit obtained by warp stitch technology on the basis of synthetic yarns and comprising two textile surfaces of respective textile structures that may be identical or different, the surfaces being interconnected by spacer yarns, each surface including elastic yarns, the bandage being characterized in that said knit presents: longitudinal stretch measured in compliance with the standard EN 14704-1 lying in the range 30% to 160%; and threshold shear stress greater than or equal to 2800 Pa.

Abstract: The present invention relates to a novel composition based on ABA triblock copolymers comprising two styrene thermoplastic end blocks A and a central elastomeric block B which is a saturated olefin, comprising at least one resin chosen from the aromatic resins, that can be used in particular for producing an interface dressing with reinforcement, with a support or which is self-supported, preferably self-supported. The present invention relates to a self-supported interface dressing which can be easily handled since it has good tear strength.

Abstract: A composition including a solution at least one acrylic adhesive and particles of a cross-linked polymer having a carboxylate-group density between 2.0 and 12.0 meq/g and an average pore size between 0.005 and 1.0 ?m, usable in particular for creating an adhesive matrix suitable for any device, for example for medical aims such as a patch, a film, a strip or a dressing, preferably a dressing, or suitable for any device of the functional textile type such as a sports item.

Abstract: A novel composition including at least one styrene-block copolymer, at least one plasticiser, and particles of a cross-linked polymer having a carboxylate-group density between 2.0 and 12.0 meq/g and an average pore size between 0.005 and 1.0 ?m, usable in particular for creating an elastomer matrix suitable for any device of the type device for medical aims such as a patch, a film, a strip or a dressing, preferably a dressing, intended to be applied onto the skin or suitable for any device of the functional textile type such as a sports item.

Abstract: A method for the preparation of a gelled polysaccharide foam, which includes the following steps: (a) the preparation of a mixture including at least one solubilized polysaccharide chosen from alginates, pectic substances, carrageenans, and mixtures thereof, at least one solvent of the polysaccharide, at least one ionic crosslinking agent of the polysaccharide, the crosslinking agent being not available, optionally a plasticizer soluble into the solvent, optionally a surfactant, and optionally an additive, (b) foaming and gelling the mixture prepared at step (a) by incorporating a pH modifying gas, and (c) optionally drying the gelled foam obtained at step (b). Also, the gelled foam obtained from such a method as well as the uses thereof.

Abstract: The present invention relates to a method of diagnosis or prognosis of a non-healing or chronic wound comprising the step of determining the ratio of carnitine to ceramide and/or ceramide derivative in a sample, or the level of at least one metabolite in a sample.

Abstract: A compression bandage formed by a knit obtained by warp stitch technology, based on synthetic yarns which is made up of two textile surfaces whose textile structure is identical or different connected to each other by spacer yarns. Each textile surface has elastic yarns and the spacer yarn being a monofilament. The knit has a longitudinal elongation measured according to standard EN 14704-1 of between 30 and 160%. The textile surface which comes into contact with the skin has synthetic multifilament yarns, the filaments of which have a count of between 1.2 and 5 dtex and the number of filaments is between 15 and 150, and a dynamic coefficient of friction measured according to standard EN ISO 8295 greater than or equal to 0.25 and less than or equal to 1.2.

Abstract: A composition based on triblock copolymers of the ABA type, including two styrene thermoplastic terminal blocks A, glassy at use temperature, and an elastomeric central block B which is a saturated olefin, at least one linear polymer of the polyisobutene type having a very low molecular weight and specific crosslinked polymer particles. The composition exhibits advantageous adhesion and holding properties on the skin which are similar to the properties obtained by matrices based on silicone elastomers. They also exhibit particularly interesting cohesion.

Abstract: A composition based on triblock copolymers of the ABA type, including two styrene thermoplastic terminal blocks A, and an elastomer central block B which is a saturated olefin, and at least one polyisobutene having a very low molecular weight and optionally a diblock copolymer of AB. The present composition exhibits advantageous properties which are similar to those of silicone elastomers. Also, a dressing including such an elastomeric composition.

Abstract: The subject matter of the present invention is, according to a first aspect, a dressing comprising an interface layer, characterised in that said interface layer comprises a weave coated with an elastomeric matrix comprising metformin, the salts and the complexes thereof. The subject matter of the invention is also a dressing comprising metformin, characterised in that the percentage of metformin released after 72 hours is between 40 and 100% of the quantity of metformin inserted in the dressing. Moreover, the subject matter of the invention is a method for producing said dressing as well as the use thereof for healing a wound.

Abstract: A novel composition including at least one styrene-block copolymer, at least one plasticiser, and particles of a cross-linked polymer having a carboxylate-group density between 2.0 and 12.0 meq/g and an average pore size between 0.005 and 1.0 ?m, usable in particular for creating an elastomer matrix suitable for any device of the type device for medical aims such as a patch, a film, a strip or a dressing, preferably a dressing, intended to be applied onto the skin or suitable for any device of the functional textile type such as a sports item.

Abstract: The present invention deals with a cellularized dressing and the method for production of such a dressing, where this method preferably comprises a step of bioprinting of cells.

Abstract: Some embodiments are directed to a mobile terminal allowing the determination of information relating to a wound, including a photographic apparatus for acquiring an image of a zone containing the wound and device adapted for determining a first likelihood map associated with a first characteristic of the zone by using a first classifier; determining a second likelihood map associated with a second characteristic, by using a second classifier, distinct from the first classifier; segmenting the image into regions of homogeneous colour; matching the regions with the first and second maps, and adapting these regions so as to determine regions corresponding substantially to the wound, and determine these items of information on the basis of these regions and displaying them on a screen of the terminal.

Abstract: A compression bandage in the form of a knit obtained with warp knit technology, formed of synthetic yarns and composed of two textile surfaces having the same or different textile structure, linked together by spacer threads, each surface has elastic yarns, and the spacer threads of the knit are multifilaments. The knit has longitudinal elongation measured as per standard EN 14704-1 of between 30 and 160% and threshold shear stress equal to or higher than 2800 Pa and/or conformability equal to or lower than 65 mm.

Abstract: The invention is directed to a light source device comprising a light emitting element for emitting a blue light having a wavelength ranging from 435 to 500 nm, the light source device being configured to provide the blue light to at least one cell at a transmitted fluence ranging from 0.01 to 18. J/cm2 to promote or induce growth and proliferation of the cell and wherein the light emitting element has a power density ranging from 0.05 to 30 mW/cm2. The invention is also directed to a light source assembly comprising a product adapted to be in contact with the skin or a wound and a light source device connected to the product for providing blue light to at least one skin cell, preferably of the wound.

Abstract: A light source device including a light emitting element for emitting a light having the following characteristics: a wavelength ranging from 435 to 520 nm, and a power density greater than 20 mW/cm2, the light source device provides an effective fluence to any contaminating and/or pathogenic agent greater than 11 J/cm2. Also, a light source assembly including a product adapted to be in contact with a support or a medium, preferably the skin or a wound and a light source device connected to the product for providing light to at least one contaminating and/or pathogenic agent present on a support or in a medium.

Abstract: The invention relates to a dermatological treatment device (1) including a laser head (2) capable of shooting a laser beam (3) towards a target region (4) of the skin (5) of a patient, a pyrometer (6) capable of measuring the temperature (T) of the skin (5) in said target region (4), a timer (7) capable of measuring the duration (D) of the laser shot, and a control means (8) capable of selectively activating or deactivating a laser shot, the control means (8) being configured to deactivate the laser shot when the duration (D) of the shot reaches a duration threshold in seconds (Sd) as determined by a linear function in the form Sd=(To?T)/C, where T is the measured temperature (T) of the skin, To is a target temperature, and C is an average heating coefficient of the skin.

Abstract: The invention relates to a device (1) for dermatological treatment, comprising a laser head (2) suitable for directing a laser beam (3) towards a target zone (4), at least one fan (5) suitable for dissipating the heat emitted by the laser head (2), and at least one monitoring means (6) suitable for detecting a fault in at least one fan (5) and for controlling at least one means (7) for inhibiting the laser beam (3) when a fault is detected.

Abstract: A composition including a solution at least one acrylic adhesive and particles of a cross-linked polymer having a carboxylate-group density between 2.0 and 12.0 meq/g and an average pore size between 0.005 and 1.0 ?m, usable in particular for creating an adhesive matrix suitable for any device, for example for medical aims such as a patch, a film, a strip or a dressing, preferably a dressing, or suitable for any device of the functional textile type such as a sports item.